Medtronic saw an 8 percent increase in total revenue and a 4 percent increase in spinal revenue in the second quarter of its fiscal year, compared with the same period last year, according to a report from Medtronic.
In Medtronic’s spinal sector, revenue from core spinal products, including Kyphon, increased 2 percent and biologics revenue grew 12 percent, both on a constant currency basis.
Outside the United States, the company’s spinal revenue grew 10 percent on a constant currency basis, driven by solid growth everywhere except Europe.
Read the release on Medtronic’s Q3 spinal revenue.
From findings on cervical disc replacement to total knee replacement, Becker’s reported on eight spine and orthopedic studies since March…
Researchers at UMass Chan Medical School in Worcester, Mass., have created an algorithm to predict total knee replacement outcomes in…
Orthopaedic Solutions Management has acquired Orlando Hand Surgical Associates, marking its eighth acquisition. OHSA was founded in 2000 and has…
Comments are closed.